Cited by 14Mental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Disorders

Treatment adequacy of anxiety disorders among young adults in Finland

Open access
Kasteenpohja, Teija, Marttunen, Mauri, Aalto-Setälä, Terhi, Perälä, Jonna, Saarni, Samuli I., Suvisaari, Jaana·2016·BMC Psychiatry

Abstract

BACKGROUND: Anxiety disorders are common in early adulthood, but general population studies concerning the treatment adequacy of anxiety disorders taking into account appropriate pharmacological and psychological treatment are scarce. The aims of this study were to examine treatments received for anxiety disorders in a Finnish general population sample of young adults, and to define factors associated with receiving minimally adequate treatment and with dropping out from treatment. METHODS: A questionnaire containing several mental health screens was sent to a nationally representative two-stage cluster sample of 1894 Finns aged 19 to 34 years. All screen positives and a random sample of screen negatives were invited to a mental health assessment including a SCID interview. For the final diagnostic assessment, case records from mental health treatments for the same sample were obtained. This article investigates treatment received, treatment adequacy and dropouts from treatment of 79 participants with a lifetime anxiety disorder (excluding those with a single specific phobia). Based on all available information, receiving antidepressant or buspirone medication for at least 2 months with at least four visits with any type of physician or at least eight sessions of psychotherapy within 12 months or at least 4 days of hospitalization were regarded as minimally adequate treatment for anxiety disorders. Treatment dropout was rated if the patient discontinued the visits by his own decision despite having an adequate treatment strategy according to the case records. RESULTS: Of participants with anxiety disorders (excluding those with a single specific phobia), 41.8 % had received minimally adequate treatment. In the multivariate analysis, comorbid substance use disorder was associated with antidepressant or buspirone medication lasting at least 2 months. Those who were currently married or cohabiting had lower odds of having at least four visits with a physician a year. None of these factors were associated with the final outcome of minimally adequate treatment or treatment dropout. Participants with comorbid personality disorders received and misused benzodiazepines more often than others. CONCLUSIONS: More efforts are needed to provide adequate treatment for young adults with anxiety disorders. Attention should be paid to benzodiazepine prescribing to individuals with personality disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12888-016-0766-0

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Less than 15% of people with diagnosed anxiety receive treatment conforming to evidence-based recommendations.

    “Importantly, the proportion of patients with anxiety disorders who receive adequate treatment is still much lower (Roberge et al., 2015; Kasteenpohja et al., 2016), even in the US, with less than 15% of people with diagnosed anxiety receiving treatment which conforms with evidence-based recommendations (Roberge et al., 2015; Kasteenpohja et al., 2016).”

    From Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries (2018) · cites this paper as Kasteenpohja et al., 2016

    The Discussion (page unavailable) reports that about 14% of all participants with anxiety disorders in the earlier NCS-R survey received minimally adequate treatment, supporting the less-than-15% figure for that survey. But the paper's own Results report 41.8% among young adults in Finland, so the figure is not a general finding of this study; the cited passage also does not explicitly identify the NCS-R survey as US-based. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 44 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. [12]Alonso J Lepine JP ESEMeD/MHEDEA 2000 Scientific Committee Overview of key data from the European study of the epidemiology of mental disorders (ESEMeD) J Clin Psychiatry 2007 68 Suppl 2 3 9 17288501
  2. [31]First MB Spitzer RL Gibbon M Williams JBW Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Patient Edition (SCID I/P, 2/2001 Revision) 2001 New York State Psychiatric Institute, Biometrics Research Department
  3. [39]National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. In: NICE guidance. National Institute for Health and Care Excellence. 2011 http://www.nice.org.uk/guidance/cg113. Accessed Jan 2011. 31961629

Cited by

Sorted by citations

Authors
Kasteenpohja, T., Marttunen, M., Aalto-Setälä, T., Perälä, J., Saarni, S. I., & Suvisaari, J.
Affiliations
  • University of Helsinki (FI)
  • University of Turku (FI)
  • Tampere University (FI)
Corresponding author
Kasteenpohja, Teija
Venue
BMC Psychiatry
Published
2016-03-15
Volume
16
Issue
1
Pages
63-63
ISSN
1471-244X (ISSN-L)
OpenAlex
W2342008332
Cited by
14
References
44
Citations by year
2025: 3 · 2024: 2 · 2023: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1
FWCI
2.10
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion, other-oa)
Funders
  • Suomalainen Tiedeakatemia (FI) (210714)
  • The Yrjö Jahnsson Foundation
  • The Jalmari and Rauha Ahokas Foundation
  • The National Graduate School of Clinical investigation
  • The Doctoral Programme in Clinical Research of the University of Helsinki
  • Suomen Lääketieteen Säätiö (FI)
  • The Finnish Psychiatric Association
  • The pharmaceutical company H. Lundbeck A/S
  • Emil Aaltosen Säätiö (FI)
  • Päivikki ja Sakari Sohlbergin Säätiö (FI)
Topics
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
anxiety disorders, young adults, treatment adequacy, treatment discontinuation, antidepressants, buspirone, benzodiazepines, substance use comorbidity, personality disorders, psychotherapy, physician visits, marital status, Finland
MeSH terms
Adult, Antidepressive Agents, Anxiety Disorders, Buspirone, Female, Finland, Hospitalization, Humans, Male, Patient Dropouts, Psychotherapy, Surveys and Questionnaires, Anti-Anxiety Agents, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review